Musi Riverfront Development Corp says the riverbed contains no heavy metals or hazardous substances, while environmental activists argue that pharmaceutical residues and antimicrobial‑resistance markers have been ignored. The clash over data threatens the project's environmental clearance.
Key Takeaways
- MRDCL states sediment is free of heavy metals and suitable for development.
- Activists claim the EIA omitted pharmaceutical residues and AMR markers.
- Any localized contaminated material will be isolated and disposed of as per regulations.
The stretch of the Musi River between the twin reservoirs and Bapughat, earmarked for Phase‑I of the riverfront project, has been declared "free of hazardous material" by MRDCL. This statement rests on baseline soil and sediment studies presented to the State Expert Appraisal Committee.
Historical Background
For decades the Musi River has been the primary conduit for industrial effluents and domestic sewage in Hyderabad. Repeated water‑quality alerts between 2010‑2015 spurred the government to launch the Musi Riverfront Development Project, aiming to revitalize the waterway while promoting urban growth.
Environmental Data
According to MRDCL, analysis of 24 sampling points showed negligible heavy‑metal concentrations, well within prescribed limits. Contamination was largely organic—nutrient enrichment and microbial load linked to sewage inflows—while hazardous chemicals were absent from the report.
Why This Matters
BozokMedia analysis shows that overlooking pharmaceutical residues and antimicrobial‑resistance (AMR) markers could compromise long‑term water safety and public health, even if heavy‑metal levels appear acceptable.
"A remediation plan that ignores drug‑derived contaminants is fundamentally incomplete," says water‑pollution expert Dr. Anjali Singh.
Activists' Objections
Retired scientist Babu Rao Kalapala of the ‘Scientists for People’ collective points to a peer‑reviewed 2026 study in *Environmental Chemistry and Eco‑toxicology* that found the Musi River carries the highest concentrations of bulk drug components such as Telmisartan, Atenolol, beta‑blockers, Paracetamol, Tramadol and Erythromycin among seven Indian rivers surveyed.
Frequently Asked Questions
Q1: Did MRDCL test for pharmaceutical residues?
A: The 692‑page EIA does not explicitly mention such testing, prompting activists to demand a supplemental analysis.
Q2: What happens if hazardous material is found during excavation?
A: MRDCL assures that any localized contaminated material will be identified, isolated and disposed of in compliance with environmental regulations.